700-02-7

Basic information

• Product Name: ADENINE N(1)-OXIDE MONOHYDRATE, 98
• Synonyms: ADENINE-N1-OXIDE;ADENINE N(1)-OXIDE MONOHYDRATE, 98;adenine1-n-oxide;adenine1-oxide;adenine-n-oxide;Adenine N(1)-oxide monohydrate;adenine N(sup 1)-oxide;6-Amino-9H-purine 1-oxide
• CAS NO: 700-02-7
• Molecular Formula: C₅H₅N₅O
• Molecular Weight: 151.1261
• EINECS: 211-835-7
• Mol File: 700-02-7.mol
• Article Data: 4

Chemical Properties

• Melting Point: 302°C (rough estimate)
• Boiling Point: 273.11°C (rough estimate)
• Flash Point: 390.164°C
• Appearance: /
• Density: 1.4456 (rough estimate)
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.9000 (estimate)
• Storage Temp.: -20°C
• PKA: pK1: 2.69(+1);pK2: 8.49(0) (25°C)
• CAS DataBase Reference: ADENINE N(1)-OXIDE MONOHYDRATE, 98(CAS DataBase Reference)
• NIST Chemistry Reference: ADENINE N(1)-OXIDE MONOHYDRATE, 98(700-02-7)
• EPA Substance Registry System: ADENINE N(1)-OXIDE MONOHYDRATE, 98(700-02-7)

Safety Data

• Safety Statements: S22:Do not inhale dust.; S24/25:Avoid contact with skin and eyes.
• Hazardous Substances Data: 700-02-7(Hazardous Substances Data)

Usage

General Description

ADENINE N(1)-OXIDE MONOHYDRATE, 98 is a chemical compound with a purity of 98%. It is a derivative of adenine, which is one of the four nucleobases in the nucleic acid of DNA and RNA. Adenine N(1)-oxide monohydrate is a stable and water-soluble compound that has potential applications in biochemical and research laboratories. Its high purity makes it suitable for use in various laboratory experiments and processes that require a reliable and consistent source of adenine N(1)-oxide monohydrate. ADENINE N(1)-OXIDE MONOHYDRATE, 98 is an important building block in the field of molecular biology, biochemistry, and pharmaceutical research.

InChI:InChI=1/C5H5N5O/c6-4-3-5(8-1-7-3)9-2-10(4)11/h1-2H,6H2,(H,7,8,9)

Upstream product

• 73-24-5 7H-purin-6-ylamine 
• 66224-66-6 adenine 

Downstream Products

• 186692-41-1 2-chloro-6-phenylmethylamino-9-iso-propylpurine 
• 5451-40-1 2,6 dichloropurine 
• 39639-47-9 N⁶-benzyl-2-chloroadenine 
• 101622-53-1 2-chloro-6-benzylamino-9-methylpurine 
• 5167-14-6 hypoxanthine 1-N-oxide 

Relevant articles and documents

Synthesis of (+)-agelasine C. A structural revision

An efficient synthesis of (+)-agelasine C has been achieved from ent-halimic acid. The structure and absolute configuration of the natural product (-)-agelasine C was established and a structure for epi-agelasine C, is proposed.

Synthesis and biological activities of C-2, N-9 substituted 6- benzylaminopurine derivatives as cyclin-dependent kinase inhibitor

In this study, C-2, N-9 substituted 6-benzylaminopurine derivatives were synthesized and their inhibitory effects on cyclin-dependent kinase (CDK2) were evaluated. The effect of substituents at the C-2 and N-9 positions of substituted purine was investigated. Among the compounds tested, compound 7b- iii (6-benzylamino-2-thiomorpholinyl-9-isopropylpurine) was the most active inhibitor (IC50 = 0.9 μM). Compound 7b-iii showed 10-fold higher activity compared to olomoucine and almost the same activity as roscovitine. Results from structure-activity relationship studies should allow the design of more potent and selective CDK inhibitors, which may provide an effective therapy for cancer or other CDK dependent diseases.